As of 2025-04-24, the Fair Value of OncoCyte Corp (OCX) is -10.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.92 USD, the upside of OncoCyte Corp is -463.20%.
With the market price of 2.92 USD and our fair value calculation, OncoCyte Corp (OCX) is not a good investment. Investing in OCX stocks now will result in a potential loss of 463.20%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -29.93 | -64.10 | -72.90 | -27.78 | -60.66 | -51.07 |
| YoY growth | -33.44% | -114.17% | -13.73% | 61.89% | -118.36% | -43.56% |
| Market Cap (mil) | 83.51 |
| P/E | |
| Forward P/E |
| EPS | -2.12 |
| Avg earnings growth rate | -43.56% |
| TTM earnings | -60.66 |